Showing posts with the label MercksShow all
October 27, 2021
Philippines to receive 300,000 courses of Merck's COVID-19 pill
An experimental COVID-19 therapy tablet, referred to as molnupiravir and being developed by Merck & Co Inc and Rid…
Read more
October 26, 2021
France says it has ordered 50,000 doses of Merck's COVID-19 antiviral pill
The Merck emblem is seen on an indication on the Merck & Co campus in Rahway, New Jersey, U.S., July 12, 2018. REU…
Read more
October 25, 2021
Indonesia in talks to buy Merck's COVID-19 antiviral pill - minister
An experimental COVID-19 remedy tablet, referred to as molnupiravir and being developed by Merck & Co Inc and Ridg…
Read more
October 25, 2021
EU regulator starts real-time review of Merck's COVID-19 pill
The Merck brand is seen at a gate to the Merck & Co campus in Rahway, New Jersey, U.S., July 12, 2018. REUTERS/Bre…
Read more
October 13, 2021
Will Merck’s Covid-19 pill be available to lower-income countries?
Molnupiravir , the investigational Covid-19 capsule developed by Merck (MSD) and Ridgeback Biotherapeutics, has been h…
Read more
October 08, 2021
Two Indian drugmakers seek to end Merck's molnupiravir trials for moderate COVID-19
An experimental COVID-19 therapy tablet known as molnupiravir being developed by Merck & Co Inc and Ridgeback Biot…
Read more
October 07, 2021
Europe approves Merck's plant to make J&J COVID-19 vaccine
Oct 7 (Reuters) – The European Medicines Company (EMA) mentioned on Thursday it had authorised U.S. drugmaker Merck &a…
Read more